Invasive breast cancer risk down for female child cancer survivors

For childhood cancer survivors, the rates of invasive breast cancer have decreased over time, according to a study published online Oct. 13 inJAMA Oncology.Tara O. Henderson, M.D., M.P.H., from

Updated on: January 02,2024

Invasive breast cancer risk down for female child cancer survivors

For childhood cancer survivors, the rates of invasive breast cancer have decreased over time, according to a study published online Oct. 13 inJAMA Oncology.Tara O. Henderson, M.D., M.P.H., from

Updated on:January 02,2024

Enhanced treatment of liver carcinoma with a drug-eluting hydrogel

by Stewart Han, Terasaki Institute for Biomedical InnovationScientists from the Terasaki Institute for Biomedical Innovation (TIBI) have developed an injectable or catheter-administered hydrogel with

Updated on: January 02,2024

Enhanced treatment of liver carcinoma with a drug-eluting hydrogel

by Stewart Han, Terasaki Institute for Biomedical InnovationScientists from the Terasaki Institute for Biomedical Innovation (TIBI) have developed an injectable or catheter-administered hydrogel with

Updated on:January 02,2024

Novel mechanism supports antitumor response and T-cell survival

by Melissa Rohman,Northwestern UniversityRepresentative composite image of a breast cancer specimen stained by multi-color IHC comprising CD8, Ki67, GCLC, GPX4, 923 A2AR, PanCK and DAPI. Represe

Updated on: April 30,2024

Novel mechanism supports antitumor response and T-cell survival

by Melissa Rohman,Northwestern UniversityRepresentative composite image of a breast cancer specimen stained by multi-color IHC comprising CD8, Ki67, GCLC, GPX4, 923 A2AR, PanCK and DAPI. Represe

Updated on:April 30,2024

Metabolite from pomegranates improves the function of immune cells in their fight against cancer

byEcole Polytechnique Federale de LausanneGraphical abstract. Credit:Immunity(2022). DOI: 10.1016/j.immuni.2022.09.014Researchers from the Georg-Speyer-Haus in Frankfurt am Main, Ger

Updated on: January 04,2024

Metabolite from pomegranates improves the function of immune cells in their fight against cancer

byEcole Polytechnique Federale de LausanneGraphical abstract. Credit:Immunity(2022). DOI: 10.1016/j.immuni.2022.09.014Researchers from the Georg-Speyer-Haus in Frankfurt am Main, Ger

Updated on:January 04,2024

Immunotherapy in first-line standard therapy significantly improves survival in metastatic or recurrent cervical cancer

byVall d'Hebron Institute of OncologyCredit: CC0 Public DomainPublished inThe Lancet, results of the randomized phase III BEATcc academic trial (ENGOT-Cx10/GEICO 68-C/JGOG1084/GOG-3030

Updated on: January 26,2024

Immunotherapy in first-line standard therapy significantly improves survival in metastatic or recurrent cervical cancer

byVall d'Hebron Institute of OncologyCredit: CC0 Public DomainPublished inThe Lancet, results of the randomized phase III BEATcc academic trial (ENGOT-Cx10/GEICO 68-C/JGOG1084/GOG-3030

Updated on:January 26,2024

Team establishes positive clinical impact of the Multidisciplinary Molecular Tumor Board

byThe University of Hong KongCredit: Unsplash/CC0 Public DomainA collaborative group led by the Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, the Univers

Updated on: January 08,2024

Team establishes positive clinical impact of the Multidisciplinary Molecular Tumor Board

byThe University of Hong KongCredit: Unsplash/CC0 Public DomainA collaborative group led by the Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, the Univers

Updated on:January 08,2024

Minimally invasive surgery may be good option for people with pancreatic cancer

by Dennis ThompsonMinimally invasive surgery works just as well as full-scale open surgery in removing early-stage pancreatic cancers, allowing patients a faster recovery with less infection risk, a n

Updated on: January 08,2024

Minimally invasive surgery may be good option for people with pancreatic cancer

by Dennis ThompsonMinimally invasive surgery works just as well as full-scale open surgery in removing early-stage pancreatic cancers, allowing patients a faster recovery with less infection risk, a n

Updated on:January 08,2024

New bladder cancer classification predicts treatment response

byCedars-Sinai Medical CenterStudy design and gene signatures of patients with high-risk NMIBC according to BCG response subtypes (BRS). Credit:Science Translational Medicine(2023).

Updated on: January 11,2024

New bladder cancer classification predicts treatment response

byCedars-Sinai Medical CenterStudy design and gene signatures of patients with high-risk NMIBC according to BCG response subtypes (BRS). Credit:Science Translational Medicine(2023).

Updated on:January 11,2024

Prostate cancer is the second-leading cancer among men. Here's what to know about it

by Erin Kayata,Northeastern UniversityCredit: Pixabay/CC0 Public DomainCancer rates, especially among young people, are on the rise. There's expected to be 2 million new cancer diagnoses in

Updated on: April 06,2024

Prostate cancer is the second-leading cancer among men. Here's what to know about it

by Erin Kayata,Northeastern UniversityCredit: Pixabay/CC0 Public DomainCancer rates, especially among young people, are on the rise. There's expected to be 2 million new cancer diagnoses in

Updated on:April 06,2024

The 'Goldilocks' principle for curing brain cancer

by University of MinnesotaCancer cell during cell division. Credit: National Institutes of HealthIn the story of Goldilocks, a little girl tastes three different bowls of porridge to find which i

Updated on: April 10,2024

The 'Goldilocks' principle for curing brain cancer

by University of MinnesotaCancer cell during cell division. Credit: National Institutes of HealthIn the story of Goldilocks, a little girl tastes three different bowls of porridge to find which i

Updated on:April 10,2024

Examining resistance to immunotherapy in ovarian cancer

byMemorial Sloan Kettering Cancer CenterTME of HGSOC at single-cell resolution.a, Overview of the MSK SPECTRUM cohort and specimen collection workflow.b, UMAP plot of cells profiled

Updated on: December 28,2023

Examining resistance to immunotherapy in ovarian cancer

byMemorial Sloan Kettering Cancer CenterTME of HGSOC at single-cell resolution.a, Overview of the MSK SPECTRUM cohort and specimen collection workflow.b, UMAP plot of cells profiled

Updated on:December 28,2023

A comprehensive proteogenomic dataset to help cancer researchers unravel molecular mysteries

by National Institutes of HealthTumor types and data types of the CPTAC pan-cancer dataset. Overview of the available molecular data types for the CPTAC pan-cancer cohort (n= 1072, see Tabl

Updated on: February 20,2024

A comprehensive proteogenomic dataset to help cancer researchers unravel molecular mysteries

by National Institutes of HealthTumor types and data types of the CPTAC pan-cancer dataset. Overview of the available molecular data types for the CPTAC pan-cancer cohort (n= 1072, see Tabl

Updated on:February 20,2024